What Antibiotics Are Prescribed for Diverticulitis?

The most commonly prescribed antibiotics for diverticulitis fall into two main camps: a combination of metronidazole with a fluoroquinolone (usually ciprofloxacin or levofloxacin), or amoxicillin-clavulanate on its own. Which one you get depends on whether you are being treated at home or in the hospital, how severe the episode is, and whether you have any drug allergies or belong to a population that requires extra caution. But the antibiotic landscape for diverticulitis has been shifting over the past decade, with growing evidence that mild, uncomplicated cases may not need antibiotics at all.

The Standard Outpatient Regimens

If you are sent home with a prescription for diverticulitis, you will almost certainly receive one of two regimens. The traditional choice has been metronidazole paired with a fluoroquinolone, most often ciprofloxacin. The logic is straightforward: diverticulitis involves infection driven by gut bacteria, and the treatment needs to cover both anaerobic organisms (the oxygen-avoiding bacteria that thrive deep in the colon) and gram-negative rods (a broad category of common gut bacteria). Metronidazole handles the anaerobes, while ciprofloxacin or levofloxacin covers the gram-negative side.¹

The alternative is amoxicillin-clavulanate, sold under the brand name Augmentin. This single pill covers both anaerobes and gram-negative bacteria on its own, which makes it simpler for patients to manage. A large cohort study comparing these two approaches across more than 100,000 patients found no meaningful difference in hospital admissions, urgent surgery, or elective surgery over one to three years of follow-up.² In practical terms, both regimens work about equally well for uncomplicated diverticulitis treated at home.

Other outpatient combinations exist but are less common. Trimethoprim-sulfamethoxazole (Bactrim) paired with metronidazole is sometimes used, and so is cephalexin with metronidazole.¹ These tend to appear when a patient has allergies that rule out the first-line options, or when fluoroquinolones are being avoided due to safety concerns.

Why Fluoroquinolones Are Losing Favor

For years, ciprofloxacin plus metronidazole was the reflexive choice. That has been changing. Fluoroquinolones carry a well-documented list of serious side effects, including tendon damage, nerve problems, and mood changes, prompting the FDA to issue multiple safety warnings. These aren’t theoretical risks for most patients, but they’ve made many clinicians rethink whether the combination is worth it when amoxicillin-clavulanate works just as well. One expert review of outpatient diverticulitis management noted that fluoroquinolone use is associated with multiple potential harms, while metronidazole itself causes significant gastrointestinal side effects like nausea, metallic taste, and appetite loss.³

The shift toward amoxicillin-clavulanate isn’t just about avoiding side effects. In the Medicare population specifically, the combination of metronidazole with a fluoroquinolone was associated with a slightly higher risk of Clostridioides difficile infection compared to amoxicillin-clavulanate alone.² C. difficile is a dangerous gut infection that can develop when antibiotics wipe out protective bacteria, and older adults are especially vulnerable. That finding gives amoxicillin-clavulanate a slight edge on the safety side for people over 65.

A comparison of fluoroquinolone-based regimens versus non-fluoroquinolone regimens in a hospital setting found comparable outcomes for length of stay, 30-day readmission, transition from intravenous to oral therapy, and progression to surgery.⁴ So regardless of the setting, fluoroquinolones don’t appear to offer a clinical advantage that would justify their extra risk profile.

Inpatient Antibiotics for More Severe Cases

When diverticulitis lands you in the hospital, treatment usually starts with intravenous antibiotics. The specific drugs depend on the hospital’s protocols and the severity of the episode. A common intravenous regimen mirrors the outpatient logic: metronidazole given by IV alongside a fluoroquinolone or a cephalosporin (such as cefuroxime or a third-generation cephalosporin). Broader-spectrum options like piperacillin-tazobactam (Zosyn) or carbapenems such as ertapenem may be used when the infection is more severe or when there’s concern about resistant organisms.

The choice of inpatient antibiotic matters less than you might think. One randomized trial found that four days of intravenous ertapenem was just as effective as a standard seven-day course for uncomplicated sigmoid diverticulitis.⁵ And a study comparing short-course versus long-course IV treatment found no difference in recurrence-free survival, with treatment failure occurring in only about 1.6% of all patients.⁶

The trend in hospital care mirrors the outpatient world: shorter is usually fine, and the old practice of keeping patients on IV antibiotics for a week or more is increasingly seen as unnecessary for uncomplicated cases.

How Long Do You Need to Take Them?

Traditional teaching called for 7 to 10 days of antibiotics for a diverticulitis episode. More recent evidence suggests that shorter courses work just as well. A randomized trial comparing a single day of antibiotic treatment to four days for right-sided uncomplicated diverticulitis found no significant differences in treatment failure, 30-day readmission, or recurrence over a median follow-up of about two and a half years.⁷ Readmission rates at 30 days were roughly 9% and 12% for the one-day and four-day groups respectively, a difference that was not statistically meaningful.

This pattern holds across multiple studies. The research consistently points in the same direction: for uncomplicated diverticulitis, there’s no clear benefit to prolonging antibiotics beyond a few days. Your doctor may still prescribe a 7-day course out of habit or because guidelines at their institution haven’t caught up with the literature. If you’re tolerating the medication well and improving, that’s not harmful. But if side effects are making you miserable, it’s reasonable to ask whether a shorter course would suffice.

Do You Even Need Antibiotics for Mild Diverticulitis?

This is where the conversation has shifted most dramatically. Several well-designed trials, particularly from Scandinavia, have compared antibiotics to observation alone for first-time, uncomplicated diverticulitis. The findings have been consistent enough to prompt guideline changes in some countries. A commentary in the evidence-based medicine literature concluded that antibiotics may not improve short-term or long-term outcomes in acute uncomplicated diverticulitis.⁸

Outpatient data from a large study did show that patients with mild uncomplicated diverticulitis who received antibiotics had a modestly lower rate of hospital admissions compared to those who didn’t (about 3.3% versus 4.2%).¹ That difference is statistically significant but small in absolute terms, which is why the answer isn’t a clean yes or no. For most people with a mild episode, watchful waiting with pain management and a temporary diet change may be perfectly reasonable. For others, especially those with complicating factors or higher initial inflammatory markers, antibiotics still make sense.

C-reactive protein levels measured early in the episode can help with this decision. Research has found that CRP levels above about 173 mg/L at the initial emergency evaluation predict more serious complications, and those patients tend to need drainage or surgery rather than just antibiotics.⁹ If your CRP comes back low and imaging shows no abscess, you may be a good candidate for the no-antibiotic approach. This is a conversation to have with your doctor, not a decision to make based on an article.

Diverticulitis During Pregnancy

Pregnancy adds a layer of complexity because many of the standard diverticulitis antibiotics carry fetal risks. A review of reported cases found that amoxicillin-clavulanate is considered the first-line oral antibiotic for pregnant patients, followed by trimethoprim with metronidazole, or cephalexin with metronidazole. For intravenous treatment, the same review lists amoxicillin-clavulanate as first-line, followed by cefuroxime with metronidazole.¹⁰

Some important timing restrictions apply. Amoxicillin-clavulanate should be avoided in the third trimester because of an increased risk of necrotizing enterocolitis in the newborn. Trimethoprim should be avoided in the first trimester because it interferes with folate metabolism. Fluoroquinolones, the backbone of many non-pregnant diverticulitis regimens, are not routinely used during pregnancy at all, and consultation with a maternal-fetal medicine specialist is recommended before considering them.¹⁰ Diverticulitis in pregnancy is uncommon, but when it does happen, the antibiotic decision is genuinely complicated and should involve a specialist.

Immunocompromised Patients Face Higher Stakes

People with weakened immune systems, whether from medications like corticosteroids or chemotherapy, organ transplant drugs, or conditions like HIV, tend to have worse outcomes from diverticulitis. An international registry study found that severely immunocompromised patients had longer hospital stays and different treatment patterns compared to those with healthy immune function.¹¹ Moderately immunocompromised patients had a median hospital stay of eight days, compared to six days for those with normal immunity.

The watchful-waiting strategy mentioned earlier, where mild diverticulitis is managed without antibiotics, is generally not considered appropriate for immunocompromised patients. Their blunted immune response means they’re less able to contain the infection on their own, and symptoms may understate the actual severity. Broader-spectrum antibiotics and closer monitoring are typically the safer course. Practice varies by institution, but most clinicians err on the aggressive side for this group.

Rare but Serious Side Effects to Watch For

The standard diverticulitis antibiotics are prescribed millions of times a year and are generally well tolerated. But rare adverse reactions do occur and are worth knowing about. One reported case involved a 61-year-old woman who developed drug-induced immune thrombocytopenia, a condition where antibodies triggered by the drug destroy platelets, within 24 hours of starting ciprofloxacin and metronidazole. Her platelet count dropped to dangerous levels but recovered quickly once the antibiotics were stopped.¹²

This isn’t a reason to panic about taking these medications, but it illustrates why you should report any unusual bleeding, bruising, or symptoms that start shortly after beginning antibiotics. The more common side effects are far less dramatic: nausea, diarrhea, and the metallic taste that metronidazole is famous for. Fluoroquinolones can cause tendon pain, especially in the Achilles tendon, and this risk is higher in people over 60 and those also taking corticosteroids.

Rifaximin for Preventing Recurrence

Once a diverticulitis episode resolves, the next question is how to prevent it from coming back. Rifaximin is a gut-targeted antibiotic that stays mostly in the intestine rather than being absorbed into the bloodstream, which gives it a different profile from the antibiotics used to treat acute episodes. A proof-of-concept study found that intermittent rifaximin combined with fiber supplements reduced the recurrence rate to about 10% over a year, compared to roughly 19% with fiber supplements alone.¹³ Among patients who had been diagnosed for more than a year, the difference was even starker.

A broader evidence review concluded that cyclical rifaximin combined with a high-fiber diet appears safe and effective for managing symptomatic uncomplicated diverticular disease, though the cost-effectiveness of long-term use remains unclear.¹⁴ Rifaximin isn’t cheap, and most insurance plans require prior authorization. It’s used primarily in patients with frequent recurrences where the burden of repeated acute episodes justifies the ongoing cost and effort.

The Microbiome Question

One of the more interesting threads in recent diverticulitis research is the role of the gut microbiome. Antibiotics, by definition, alter the bacterial landscape of the colon, and since diverticulitis arises in the colon, this creates a somewhat circular problem: the treatment may be reshaping the very environment that contributed to the disease. A review of emerging evidence noted that the role of antibiotics in uncomplicated diverticulitis merits reconsideration, in part because of newly proposed mechanisms linking the microbiome to diverticular disease.¹⁵

This doesn’t mean you should refuse antibiotics if your doctor prescribes them for a genuine diverticulitis flare. It does mean that the field is moving toward a more nuanced view where antibiotics aren’t automatically the first step for every episode. The emerging picture is that uncomplicated diverticulitis might be more of an inflammatory process than a true infection in many cases, which would explain why observation alone works for mild episodes. Complicated cases involving abscesses or perforation remain firmly in antibiotic territory, and nobody is seriously questioning that.

How Antibiotic Practice Varies Around the World

Antibiotic selection for diverticulitis is not universal. In Japan, for instance, guidelines for diverticulosis do not recommend any particular antibiotic, leaving the choice to the prescribing physician. Japanese clinicians often select antibiotics with anti-pseudomonal activity, such as piperacillin-tazobactam, even for uncomplicated cases.¹⁶ That’s a broader-spectrum approach than what most American and European guidelines recommend for uncomplicated disease, and it reflects different prescribing cultures and resistance patterns.

European practice, particularly in Scandinavia, has moved most aggressively toward the no-antibiotic approach for mild cases. The American Gastroenterological Association has acknowledged this evidence but has been slower to formally recommend skipping antibiotics entirely. In practice, this means your treatment may depend quite a bit on where you live and what your doctor trained on. If you’ve been prescribed a regimen that doesn’t match what you’ve read online, that doesn’t necessarily mean it’s wrong. It may reflect local resistance patterns, your individual risk factors, or an institution’s interpretation of the same underlying data.

Right-sided diverticulitis, which is more common in Asian populations, also presents differently from the left-sided disease that predominates in Western countries. Some of the duration studies, like the one-day versus four-day trial, specifically focused on right-sided disease.⁷ Findings from right-sided studies may not transfer seamlessly to left-sided disease, and vice versa. When reading about diverticulitis treatment, paying attention to which part of the colon was studied matters more than you’d expect.

1
PubMed Central. Outpatient use of antibiotics in uncomplicated diverticulitis decreases hospital admissions
2
PubMed Central. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis Two Nationwide Cohort Studies
3
PubMed Central. Tips for the Medical Management of Diverticulitis
4
Open Forum Infectious Diseases. 1115. Use of a Fluoroquinolone (FQ) vs. a Non-Fluoroquinolone (Non-FQ)-Based Antibiotic Regimen in the Treatment of Acute, Uncomplicated Diverticulitis
5
PubMed. Prospective randomized trial comparing short-term antibiotic therapy versus standard therapy for acute uncomplicated sigmoid diverticulitis
6
Annals of Coloproctology. Short-term Intravenous Antibiotic Treatment in Uncomplicated Diverticulitis Does Not Increase the Risk of Recurrence Compared to Long-term Treatment
7
PubMed Central. One-day versus four-day antibiotic treatment for acute right colonic uncomplicated diverticulitis: A randomized clinical trial
8
PubMed. Antibiotics may not improve short-term or long-term outcomes in acute uncomplicated diverticulitis
9
PubMed Central. C-reactive protein predicts increased severity in acute sigmoid diverticulitis
10
PubMed Central. Diverticulitis during pregnancy: A review of the reported cases
11
PubMed Central. Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry
12
PubMed Central. Ciprofloxacin and Metronidazole As Rare Culprits of Drug-Induced Immune Thrombocytopenia in the Setting of Diverticulitis Treatment
13
PubMed. One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study
14
PubMed Central. Diverticular Disease and Rifaximin: An Evidence-Based Review
15
PubMed Central. The Emerging Role of the Microbiota and Antibiotics in Diverticulitis Treatment
16
ScienceDirect / Elsevier (J Infect Chemother). Efficacy of cefmetazole in immunocompetent patients with uncomplicated colonic diverticulitis: A propensity score matching analysis